Tianyu Feng

Tianyu Feng

Auto-generated profile, based on publicly available information

Tianyu Feng

Jilin University School of Public Health

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
TFTianyu Feng
Tianyu Feng
KLKexin Li
Kexin Li
PZPingping Zheng
Pingping Zheng
YWYanjun Wang
Yanjun Wang
YLYaogai Lv
Yaogai Lv
YYyan yao
yan yao
Objective. Type 2 diabetes mellitus (T2DM) is a metabolic disease with high incidence, which has seriously affected human life and health. MicroRNA, a short-chain noncoding RNA, plays an important role in T2DM. Identification of meaningful microRNA modules and the role of microRNAs provide a basis for searching potential biomarkers of T2DM. Materials and Methods. In this study, three newly diagnosed patients with T2DM and three controls were selected for Whole Peripheral Blood RNA Sequencing to establish a microRNA library. Weighted gene coexpression network analysis (WGCNA) was applied to construct coexpression modules and to detect the trait-related microRNA modules; then, KEGG enrichment analysis was performed to predict the biological function of the interest modules, and candidate hub microRNAs were screened out by the value of module membership (MM) and protein-protein interaction (PPI) network. Result. Four microRNA modules (blue, brown, magenta, and turquoise) were highly associated with the T2DM; the number of miRNAs in these modules ranged from 41 to 469. The Fc gamma R-mediated phagocytosis pathway, Rap1 signaling pathway, MAPK signaling pathway, and Lysosome pathway were common pathways in three of the four modules. RPS27A, UBC, and RAC1 were the top three proteins in our study; their corresponding RNAs were miR-1271-5p, miR-130a-3p, miR-130b-3p, and miR-574-3p. Conclusion. In summary, this study identified blood miRNAs in human T2DM using RNA sequencing. The findings may be the foundation for understanding the potential role of miRNAs in T2DM.

6 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
TFTianyu Feng
Tianyu Feng
XZXiaolin Zhang
Xiaolin Zhang
JXJiaying Xu
Jiaying Xu
SGShang Gao
Shang Gao
XYXihe Yu
Xihe Yu
Background The latest revised Chinese guidelines for the management of dyslipidemia have lowered the 10-year risk threshold for initiating statins for primary prevention of atherosclerotic heart disease. The aim of this study was to examine the negative impact of different statin treatment initiation thresholds on diabetes in a Chinese population and to assess their health economics value. Methods In this study, we constructed an event probability-based Microsimulation model to assess the health economics value of statin therapy. The model was based on the Prediction for atherosclerotic cardio-vascular disease (ASCVD) risk in China (China-PAR) and used data from a nationally representative survey and published meta-analysis of the Chinese middle-aged and elderly population as input. We evaluated four different strategies: a 7.5% 10-year risk threshold strategy, a guideline strategy, a 15% 10-year risk threshold strategy, and a 20% 10-year risk threshold strategy. Additionally, we calculated the incremental cost per quality-adjusted life year (QALY) obtained for each strategy to better understand the economics of the various strategies. Result The incremental cost per QALY for the 10% 10-year risk threshold strategy, compared to the untreated, was $52,218.75. The incremental cost per QALY for the guideline strategy, compared to the 7.5% 10-year risk threshold strategy, was $464,614.36. These results were robust in most sensitivity analyses. Conclusion The current 10-year ASCVD risk thresholds used in China’s dyslipidemia management guidelines are cost-effective in preventing ASCVD events and should be maintained with the current statin initiation thresholds. Relaxing the initiation threshold as willingness to pay increases would be more cost-effective.

9 October 2023
Verified
Preprint
Open access
PDF file
JXJiaying Xu
Jiaying Xu
TFTianyu Feng
Tianyu Feng
XZXiaolin Zhang
Xiaolin Zhang
MLMing Li
Ming Li
SGShang Gao
Shang Gao
XYXihe Yu
Xihe Yu
Purpose In order to evaluate the effect of The Public Hospital Reform Policy (PHRP) implemented by Jilin Province in 2017 on improving the operational efficiency of public grade III level A hospitals (3A hospitals) and analyse the items in the policy that play a significant role in improving the efficiency of 3A hospitals, this research analyses whether the PHRP implemented can achieve the expected effect and help 3A hospitals improve their operations. Materials and methods The data comes from the annual health financial summary system of the Health Commission of Jilin Province.The Data envelopment analysis (DEA) was used to analyse the operational efficiency of 3A hospitals. The Malmquist index was used to support DEA findings. Tobit regression was used to analyse the impact of various reform projects in the PHRP on the operational efficiency of 3A hospitals. Results The PHRP has played a positive role in the operational efficiency of 3A hospitals. After the implementation of the PHRP, the average size efficiency score increased to 0.934, the average technical efficiency score increased by 0.063 and the average overall efficiency score improved by 0.086 of the twenty-two 3A hospitals. However, the effect is limited. Controlling the proportion of drug revenues in 3A hospitals is significantly helpful to the improvement of their operational efficiency, but the rise of patients’ treatment expenses has not been effectively controlled. Conclusions PHRP has had a positive effect on controlling drug revenues in 3A hospitals and the next step in the policy should be to find ways to reduce treatment costs to further improve efficiency in 3A hospitals.